EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $250,193 | +78.4% | 75,133 | +295.4% | 0.00% | – |
| Q2 2023 | $140,250 | -36.3% | 19,004 | -10.1% | 0.00% | – |
| Q1 2023 | $220,185 | -31.5% | 21,131 | -24.1% | 0.00% | – |
| Q4 2022 | $321,480 | -36.7% | 27,846 | +73.5% | 0.00% | -100.0% |
| Q2 2022 | $508,000 | -39.6% | 16,053 | -20.4% | 0.00% | 0.0% |
| Q1 2022 | $841,000 | +120.2% | 20,169 | +134.5% | 0.00% | – |
| Q4 2021 | $382,000 | -90.1% | 8,600 | -80.1% | 0.00% | -100.0% |
| Q4 2020 | $3,876,000 | -36.0% | 43,277 | -26.1% | 0.01% | -50.0% |
| Q3 2020 | $6,057,000 | +815.0% | 58,585 | +599.5% | 0.01% | +900.0% |
| Q2 2020 | $662,000 | +48.8% | 8,375 | +8.9% | 0.00% | 0.0% |
| Q1 2020 | $445,000 | +99.6% | 7,692 | +73.4% | 0.00% | – |
| Q1 2019 | $223,000 | – | 4,435 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |